Skip to main content
SpringerLink
Log in

Travel Medicine, Vaccines, and Transplant Tourism

  • Chapter
  • First Online:
Transplant Infections

  • 1931 Accesses

Abstract

As their overall health improves after transplant, transplant recipients may wish to experience foreign travel (including visiting friends and relatives). Such travel may entail exposures to endemic and sometimes unexpected pathogens. Transplant recipients are more likely to have complications from travel-related infections, are less likely to develop protection from vaccines, and are at higher risk for having drug interactions when they take new medications [Kotton et al. Am J Transplant. 13(Suppl 4):337–47, 2013]. In addition, active infections and vaccines are immunomodulatory and could potentially impact immunologic tolerance. This review will summarize the medical literature regarding travel medicine and travel-related vaccines in the adult transplant recipient population. “Transplant tourism” (involving travel of either the organ donor or recipient strictly for purposes of organ transplantation) will also be covered here.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Similar content being viewed by others

References

  1. Kotton CN, Hibberd PL, AST Infectious Diseases Community of Practice. Travel medicine and transplant tourism in solid organ transplantation. Am J Transplant. 2013;13 Suppl 4:337–47.

    CAS  PubMed  Google Scholar 

  2. Boggild AK, Sano M, Humar A, Salit I, Gilman M, Kain KC. Travel patterns and risk behavior in solid organ transplant recipients. J Travel Med. 2004;11(1):37–43.

    PubMed  Google Scholar 

  3. Uslan DZ, Patel R, Virk A. International travel and exposure risks in solid-organ transplant recipients. Transplantation. 2008;86(3):407–12.

    PubMed  Google Scholar 

  4. Roukens AH, van Dissel JT, de Fijter JW, Visser LG. Health preparations and travel-related morbidity of kidney transplant recipients traveling to developing countries. Clin Transplant. 2007;21(4):567–70.

    CAS  PubMed  Google Scholar 

  5. Kotton CN, Freedman DO. Chapter 8: Advising Travelers with Specific Needs: Immunocompromised Travelers. 2016 Health Information for International Travel (available at http://wwwnc.cdc.gov/travel/yellowbook/2016/advising-travelers-with-specific-needs/immunocompromised-travelers). 2016 ed. Atlanta: Centers for Disease Control and Prevention; 2016.

  6. The immunocompromised traveller. An Advisory Committee Statement (ACS). Can Commun Dis Rep. 2007;33(ACS-4):1–24.

    Google Scholar 

  7. Rubin LG, Levin MJ, Ljungman P, Davies EG, Avery R, Tomblyn M, et al. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis. 2014;58(3):e44–100.

    PubMed  Google Scholar 

  8. Fishman JA. Infection in solid-organ transplant recipients. N Engl J Med. 2007;357(25):2601–14.

    CAS  PubMed  Google Scholar 

  9. Aung AK, Trubiano JA, Spelman DW. Travel risk assessment, advice and vaccinations in immunocompromised travellers (HIV, solid organ transplant and haematopoeitic stem cell transplant recipients): a review. Travel Med Infect Dis. 2015;13(1):31–47.

    CAS  PubMed  Google Scholar 

  10. Wyplosz B, Van der Vliet D, Consigny PH, Calmus Y, Mamzer-Bruneel MF, Guillemain R, et al. Vaccinations for the traveling adult solid organ transplant recipient (excluding hematopoietic stem cell transplant recipients). Med Mal Infect. 2009;39(4):225–33.

    CAS  PubMed  Google Scholar 

  11. Williams WW, Lu PJ, O’Halloran A, Bridges CB, Kim DK, Pilishvili T, et al. Vaccination coverage among adults, excluding influenza vaccination – United States, 2013. MMWR Morb Mortal Wkly Rep. 2015;64(4):95–102.

    PubMed  PubMed Central  Google Scholar 

  12. Henning KJ, White MH, Sepkowitz KA, Armstrong D. A national survey of immunization practices following allogeneic bone marrow transplantation. JAMA. 1997;277(14):1148–51.

    CAS  PubMed  Google Scholar 

  13. Avery RK, Michaels M. Update on immunizations in solid organ transplant recipients: what clinicians need to know. Am J Transplant. 2008;8(1):9–14.

    CAS  PubMed  Google Scholar 

  14. Ballout A, Goffin E, Yombi JC, Vandercam B. Vaccinations for adult solid organ transplant recipient: current recommendations. Transplant Proc. 2005;37(6):2826–7.

    CAS  PubMed  Google Scholar 

  15. Duchini A, Goss JA, Karpen S, Pockros PJ. Vaccinations for adult solid-organ transplant recipients: current recommendations and protocols. Clin Microbiol Rev. 2003;16(3):357–64.

    PubMed  PubMed Central  Google Scholar 

  16. Kotton CN, Ryan ET, Fishman JA. Prevention of infection in adult travelers after solid organ transplantation. Am J Transplant. 2005;5(1):8–14.

    PubMed  Google Scholar 

  17. Kotton CN. Vaccination and immunization against travel-related diseases in immunocompromised hosts. Expert Rev Vaccines. 2008;7(5):663–72.

    CAS  PubMed  Google Scholar 

  18. Danziger-Isakov L, Kumar D, AST Infectious Diseases Community of Practice. Vaccination in solid organ transplantation. Am J Transplant. 2013;13(Suppl 4):311–7.

    Google Scholar 

  19. Hill DR, Ericsson CD, Pearson RD, Keystone JS, Freedman DO, Kozarsky PE, et al. The practice of travel medicine: guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2006;43(12):1499–539.

    CAS  PubMed  Google Scholar 

  20. Tomblyn M, Chiller T, Einsele H, Gress R, Sepkowitz K, Storek J, et al. Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective. Biol Blood Marrow Transplant. 2009;15(10):1143–238.

    CAS  PubMed  PubMed Central  Google Scholar 

  21. Dykewicz CA. Summary of the guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. Clin Infect Dis. 2001;33(2):139–44.

    CAS  PubMed  Google Scholar 

  22. Ljungman P, Engelhard D, de la Camara R, Einsele H, Locasciulli A, Martino R, et al. Vaccination of stem cell transplant recipients: recommendations of the Infectious Diseases Working Party of the EBMT. Bone Marrow Transplant. 2005;35(8):737–46.

    CAS  PubMed  Google Scholar 

  23. Machado CM. Reimmunization after hematopoietic stem cell transplantation. Expert Rev Vaccines. 2005;4(2):219–28.

    PubMed  Google Scholar 

  24. Kim DK, Bridges CB, Harriman KH, Centers for Disease Control and Prevention (CDC), Advisory Committee on Immunization Practices (ACIP), ACIP Adult Immunization Work Group, et al. Advisory committee on immunization practices recommended immunization schedule for adults aged 19 years or older—United States, 2015. MMWR Morb Mortal Wkly Rep. 2015;64(4):91–2.

    PubMed  PubMed Central  Google Scholar 

  25. Kumar D, Welsh B, Siegal D, Chen MH, Humar A. Immunogenicity of pneumococcal vaccine in renal transplant recipients—three year follow-up of a randomized trial. Am J Transplant. 2007;7(3):633–8.

    CAS  PubMed  Google Scholar 

  26. Centers for Disease Control and Prevention (CDC). Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2012;61(40):816–9.

    Google Scholar 

  27. Avery RK, Ljungman P. Prophylactic measures in the solid-organ recipient before transplantation. Clin Infect Dis. 2001;33 Suppl 1:S15–21.

    PubMed  Google Scholar 

  28. Molrine DC, Hibberd PL. Vaccines for transplant recipients. Infect Dis Clin North Am. 2001;15(1):273–305. xii.

    CAS  PubMed  Google Scholar 

  29. Kawano Y, Suzuki M, Kawada JI, Kimura H, Kamei H, Ohnishi Y, et al. Effectiveness and safety of immunization with live-attenuated and inactivated vaccines for pediatric liver transplantation recipients. Vaccine. 2015;33:1440–5.

    CAS  PubMed  Google Scholar 

  30. Rand EB, McCarthy CA, Whitington PF. Measles vaccination after orthotopic liver transplantation. J Pediatr. 1993;123(1):87–9.

    CAS  PubMed  Google Scholar 

  31. Measles, The Pink Book, Centers for Disease Control and Prevention, http://www.cdc.gov/vaccines/pubs/pinkbook/downloads/measpdf [Internet]. 18 February 2015. Available from: http://www.cdc.gov/vaccines/pubs/pinkbook/downloads/meas.pdf

  32. Hayney MS, Welter DL, Reynolds AM, Francois M, Love RB. High-dose hepatitis B vaccine in patients waiting for lung transplantation. Pharmacotherapy. 2003;23(5):555–60.

    PubMed  Google Scholar 

  33. Bienzle U, Gunther M, Neuhaus R, Vandepapeliere P, Vollmar J, Lun A, et al. Immunization with an adjuvant hepatitis B vaccine after liver transplantation for hepatitis B-related disease. Hepatology. 2003;38(4):811–9.

    CAS  PubMed  Google Scholar 

  34. Choy BY, Peiris JS, Chan TM, Lo SK, Lui SL, Lai KN. Immunogenicity of intradermal hepatitis B vaccination in renal transplant recipients. Am J Transplant. 2002;2(10):965–9.

    PubMed  Google Scholar 

  35. Sever MS, Kazancioglu R, Yildiz A, Turkmen A, Ecder T, Kayacan SM, et al. Outcome of living unrelated (commercial) renal transplantation. Kidney Int. 2001;60(4):1477–83.

    CAS  PubMed  Google Scholar 

  36. Jaffe D, Papadopoulos EB, Young JW, O’Reilly RJ, Prockop S, Kernan NA, et al. Immunogenicity of recombinant hepatitis B vaccine (rHBV) in recipients of unrelated or related allogeneic hematopoietic cell (HC) transplants. Blood. 2006;108(7):2470–5.

    CAS  PubMed  PubMed Central  Google Scholar 

  37. Ljungman P, Wang FZ, Nilsson C, Solheim V, Linde A. Vaccination of autologous stem cell transplant recipients with live varicella vaccine: a pilot study. Support Care Cancer. 2003;11(11):739–41.

    CAS  PubMed  Google Scholar 

  38. Hata A, Asanuma H, Rinki M, Sharp M, Wong RM, Blume K, et al. Use of an inactivated varicella vaccine in recipients of hematopoietic-cell transplants. N Engl J Med. 2002;347(1):26–34.

    PubMed  Google Scholar 

  39. Ryan ET, Kain KC. Health advice and immunizations for travelers. N Engl J Med. 2000;342(23):1716–25.

    CAS  PubMed  Google Scholar 

  40. Mutsch M, Spicher VM, Gut C, Steffen R. Hepatitis A virus infections in travelers, 1988–2004. Clin Infect Dis. 2006;42(4):490–7.

    PubMed  Google Scholar 

  41. Arslan M, Wiesner RH, Poterucha JJ, Zein NN. Safety and efficacy of hepatitis A vaccination in liver transplantation recipients. Transplantation. 2001;72(2):272–6.

    CAS  PubMed  Google Scholar 

  42. Dumot JA, Barnes DS, Younossi Z, Gordon SM, Avery RK, Domen RE, et al. Immunogenicity of hepatitis A vaccine in decompensated liver disease. Am J Gastroenterol. 1999;94(6):1601–4.

    CAS  PubMed  Google Scholar 

  43. Stark K, Gunther M, Neuhaus R, Reinke P, Schroder K, Linnig S, et al. Immunogenicity and safety of hepatitis A vaccine in liver and renal transplant recipients. J Infect Dis. 1999;180(6):2014–7.

    CAS  PubMed  Google Scholar 

  44. Jeon HJ, Ro H, Jeong JC, Koo TY, Han M, Min SI, et al. Efficacy and safety of hepatitis A vaccination in kidney transplant recipients. Transpl Infect Dis. 2014;16(3):511–5.

    CAS  PubMed  Google Scholar 

  45. Gunther M, Stark K, Neuhaus R, Reinke P, Schroder K, Bienzle U. Rapid decline of antibodies after hepatitis A immunization in liver and renal transplant recipients. Transplantation. 2001;71(3):477–9.

    CAS  PubMed  Google Scholar 

  46. Rendi-Wagner P, Korinek M, Winkler B, Kundi M, Kollaritsch H, Wiedermann U. Persistence of seroprotection 10 years after primary hepatitis A vaccination in an unselected study population. Vaccine. 2007;25(5):927–31.

    CAS  PubMed  Google Scholar 

  47. Garcia Garrido HM, Wieten RW, Grobusch MP, Goorhuis A. Response to hepatitis A vaccination in immunocompromised travelers. J Infect Dis. 2015;212:378–85.

    PubMed  Google Scholar 

  48. Jackson BR, Iqbal S, Mahon B, Centers for Disease Control and Prevention (CDC). Updated recommendations for the use of typhoid vaccine—Advisory Committee on Immunization Practices, United States, 2015. MMWR Morb Mortal Wkly Rep. 2015;64(11):305–8.

    PubMed  PubMed Central  Google Scholar 

  49. Kroon FP, van Dissel JT, Ravensbergen E, Nibbering PH, van Furth R. Impaired antibody response after immunization of HIV-infected individuals with the polysaccharide vaccine against Salmonella typhi (Typhim-Vi). Vaccine. 1999;17(23–24):2941–5.

    CAS  PubMed  Google Scholar 

  50. Begier EM, Burwen DR, Haber P, Ball R. Postmarketing safety surveillance for typhoid fever vaccines from the Vaccine Adverse Event Reporting System, July 1990 through June 2002. Clin Infect Dis. 2004;38(6):771–9.

    PubMed  Google Scholar 

  51. Ljungman P, Aschan J, Gustafsson B, Lewensohn-Fuchs I, Winiarski J, Ringden O. Long-term immunity to poliovirus after vaccination of allogeneic stem cell transplant recipients. Bone Marrow Transplant. 2004;34(12):1067–9.

    CAS  PubMed  Google Scholar 

  52. Wyplosz B, Derradji O, Hong E, Francois H, Durrbach A, Duclos-Vallee JC, et al. Low immunogenicity of quadrivalent meningococcal vaccines in solid organ transplant recipients. Transpl Infect Dis. 2015;17(2):322–7.

    CAS  PubMed  Google Scholar 

  53. Parkkali T, Kayhty H, Lehtonen H, Ruutu T, Volin L, Eskola J, et al. Tetravalent meningococcal polysaccharide vaccine is immunogenic in adult allogeneic BMT recipients. Bone Marrow Transplant. 2001;27(1):79–84.

    CAS  PubMed  Google Scholar 

  54. Patel SR, Ortin M, Cohen BJ, Borrow R, Irving D, Sheldon J, et al. Revaccination with measles, tetanus, poliovirus, Haemophilus influenzae type B, meningococcus C, and pneumococcus vaccines in children after hematopoietic stem cell transplantation. Clin Infect Dis. 2007;44(5):625–34.

    CAS  PubMed  Google Scholar 

  55. Yu JW, Borkowski A, Danzig L, Reiter S, Kavan P, Mazer BD. Immune response to conjugated meningococcal C vaccine in pediatric oncology patients. Pediatr Blood Cancer. 2007;49(7):918–23.

    PubMed  Google Scholar 

  56. Lin PL, Michaels MG, Green M, Mazariegos GV, Webber SA, Lawrence KS, et al. Safety and immunogenicity of the American Academy of Pediatrics—recommended sequential pneumococcal conjugate and polysaccharide vaccine schedule in pediatric solid organ transplant recipients. Pediatrics. 2005;116(1):160–7.

    PubMed  Google Scholar 

  57. Folaranmi T, Rubin L, Martin SW, Patel M, MacNeil JR. Use of serogroup B meningococcal vaccines in persons aged >/=10 years at increased risk for serogroup B meningococcal disease: recommendations of the Advisory Committee on Immunization Practices, 2015. MMWR Morb Mortal Wkly Rep. 2015;64(22):608–12.

    PubMed  PubMed Central  Google Scholar 

  58. Ljungman P. Vaccination of transplant recipients. In: Bowden RA, Ljungman P, Paya CV, editors. Transplant infections. Philadelphia: Lippincott Williams & Wilkins; 2003. p. 611–24.

    Google Scholar 

  59. Mileno M. Preparation of immunocompromised travelers. In: Keystone JS, Freedman DP, Nothdurft HD, Connor BA, editors. Travel Medicine. 1st ed. Edinburgh: Mosby; 2004. p. 249–55.

    Google Scholar 

  60. Staples JE, Gershman M, Fischer M, Centers for Disease Control and Prevention (CDC). Yellow fever vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2010;59(RR-7):1–27.

    Google Scholar 

  61. Gowda R, Cartwright K, Bremner JA, Green ST. Yellow fever vaccine: a successful vaccination of an immunocompromised patient. Eur J Haematol. 2004;72(4):299–301.

    CAS  PubMed  Google Scholar 

  62. Receveur MC, Thiebaut R, Vedy S, Malvy D, Mercie P, Bras ML. Yellow fever vaccination of human immunodeficiency virus-infected patients: report of 2 cases. Clin Infect Dis. 2000;31(3):E7–8.

    CAS  PubMed  Google Scholar 

  63. Tattevin P, Depatureaux AG, Chapplain JM, Dupont M, Souala F, Arvieux C, et al. Yellow fever vaccine is safe and effective in HIV-infected patients. AIDS. 2004;18(5):825–7.

    PubMed  Google Scholar 

  64. Ho YL, Enohata T, Lopes MH, De Sousa Dos Santos S. Vaccination in Brazilian HIV-infected adults: a cross-sectional study. AIDS Patient Care STDS. 2008;22:65–70.

    PubMed  Google Scholar 

  65. Kengsakul K, Sathirapongsasuti K, Punyagupta S. Fatal myeloencephalitis following yellow fever vaccination in a case with HIV infection. J Med Assoc Thai. 2002;85(1):131–4.

    PubMed  Google Scholar 

  66. Wyplosz B, Burdet C, Francois H, Durrbach A, Duclos-Vallee JC, Mamzer-Bruneel MF, et al. Persistence of yellow fever vaccine-induced antibodies after solid organ transplantation. Am J Transplant. 2013;13(9):2458–61.

    CAS  PubMed  Google Scholar 

  67. Staples JE, Bocchini Jr JA, Rubin L, Fischer M. Yellow fever vaccine booster doses: recommendations of the Advisory Committee on Immunization Practices, 2015. MMWR Morb Mortal Wkly Rep. 2015;64(23):647–50.

    PubMed  PubMed Central  Google Scholar 

  68. Gibbons RV, Rupprecht CE. Postexposure rabies prophylaxis in immunosuppressed patients. JAMA. 2001;285(12):1574–5.

    CAS  PubMed  Google Scholar 

  69. Tantawichien T, Jaijaroensup W, Khawplod P, Sitprija V. Failure of multiple-site intradermal postexposure rabies vaccination in patients with human immunodeficiency virus with low CD4+ T lymphocyte counts. Clin Infect Dis. 2001;33(10):E122–4.

    CAS  PubMed  Google Scholar 

  70. Fischer M, Lindsey N, Staples JE, Hills S, Centers for Disease Control and Prevention (CDC). Japanese encephalitis Routine vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2010;59(RR-1):1–27.

    Google Scholar 

  71. Pakakasama S, Wattanatitan S, Techasaensiri C, Yoksan S, Sirireung S, Hongeng S. Immunogenicity of a live-attenuated Japanese encephalitis vaccine in children and adolescents after hematopoietic stem cell transplantation. Bone Marrow Transplant. 2014;49(10):1307–9.

    CAS  PubMed  Google Scholar 

  72. Marin M, Guris D, Chaves SS, Schmid S, Seward JF. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2007;56(RR-4):1–40.

    Google Scholar 

  73. Panackal AA, Hajjeh RA, Cetron MS, Warnock DW. Fungal infections among returning travelers. Clin Infect Dis. 2002;35(9):1088–95.

    PubMed  Google Scholar 

  74. Bumbacea D, Arend SM, Eyuboglu F, Fishman JA, Goletti D, Ison MG, et al. The risk of tuberculosis in transplant candidates and recipients: a TBNET consensus statement. Eur Respir J. 2012;40(4):990–1013.

    PubMed  Google Scholar 

  75. Ruppe E, Armand-Lefevre L, Estellat C, Consigny PH, El Mniai A, Boussadia Y, et al. High rate of acquisition but short duration of carriage of multidrug-resistant Enterobacteriaceae after travel to the tropics. Clin Infect Dis. 2015;61(4):593–600.

    PubMed  Google Scholar 

  76. Paltansing S, Vlot JA, Kraakman ME, Mesman R, Bruijning ML, Bernards AT, et al. Extended-spectrum beta-lactamase-producing Enterobacteriaceae among travelers from the Netherlands. Emerg Infect Dis. 2013;19(8):1206–13.

    PubMed  PubMed Central  Google Scholar 

  77. Hackett PH, Roach RC. High-altitude illness. N Engl J Med. 2001;345(2):107–14.

    CAS  PubMed  Google Scholar 

  78. Ghafur A, Raza M, Labbett W, Chawla A, Smith C, Ngui SL, et al. Travel-associated acquisition of hepatitis C virus infection in patients receiving haemodialysis. Nephrol Dial Transplant. 2007;22(9):2640–4.

    PubMed  Google Scholar 

  79. Coward RA, Garrues M, Solomon LR, Gibson SP. Hepatitis C and holiday dialysis. A postal survey of UK renal units. Nephrol Dial Transplant. 2000;15(10):1715.

    Google Scholar 

  80. Parsons D, Coward RA, Woywodt A. Travel-associated acquisition of hepatitis C—implications for the renal transplant waiting list. Nephrol Dial Transplant. 2008;23(6):2104; author reply -5.

    Google Scholar 

  81. Evans RW. Ethnocentrism is an unacceptable rationale for health care policy: a critique of transplant tourism position statements. Am J Transplant. 2008;8(6):1089–95.

    CAS  PubMed  Google Scholar 

  82. Merion RM, Barnes AD, Lin M, Ashby VB, McBride V, Ortiz-Rios E, et al. Transplants in foreign countries among patients removed from the US transplant waiting list. Am J Transplant. 2008;8(4 Pt 2):988–96.

    CAS  PubMed  Google Scholar 

  83. The Declaration of Istanbul on organ trafficking and transplant tourism. Transplantation. 2008;86(8):1013–8.

    Google Scholar 

  84. Kotton CN. Transplant tourism and donor-derived parasitic infections. Transplant Proc. 2011;43(6):2448–9.

    CAS  PubMed  Google Scholar 

  85. Kotton CN. Travel and transplantation: travel-related diseases in transplant recipients. Curr Opin Organ Transplant. 2012;17(6):594–600.

    PubMed  Google Scholar 

  86. Anker AE, Feeley TH. Estimating the risks of acquiring a kidney abroad: a meta-analysis of complications following participation in transplant tourism. Clin Transplant. 2012;26(3):E232–41.

    PubMed  Google Scholar 

  87. Martin-Davila P, Fortun J, Lopez-Velez R, Norman F, Montes de Oca M, Zamarron P, et al. Transmission of tropical and geographically restricted infections during solid-organ transplantation. Clin Microbiol Rev. 2008;21(1):60–96.

    CAS  PubMed  PubMed Central  Google Scholar 

  88. Kennedy SE, Shen Y, Charlesworth JA, Mackie JD, Mahony JD, Kelly JJ, et al. Outcome of overseas commercial kidney transplantation: an Australian perspective. Med J Aust. 2005;182(5):224–7.

    PubMed  Google Scholar 

  89. Commercially motivated renal transplantation: results in 540 patients transplanted in India. The Living Non-Related Renal Transplant Study Group. Clinical transplantation. 1997;11(6):536–44.

    Google Scholar 

  90. Harling R, Turbitt D, Millar M, Ushiro-Lumb I, Lacey S, Xavier G, et al. Passage from India: an outbreak of hepatitis B linked to a patient who acquired infection from health care overseas. Public Health. 2007;121(10):734–41.

    PubMed  Google Scholar 

  91. Canales MT, Kasiske BL, Rosenberg ME. Transplant tourism: outcomes of United States residents who undergo kidney transplantation overseas. Transplantation. 2006;82(12):1658–61.

    PubMed  Google Scholar 

  92. Geddes CC, Henderson A, Mackenzie P, Rodger SC. Outcome of patients from the west of Scotland traveling to Pakistan for living donor kidney transplants. Transplantation. 2008;86(8):1143–5.

    PubMed  Google Scholar 

  93. Gill J, Madhira BR, Gjertson D, Lipshutz G, Cecka JM, Pham PT, et al. Transplant tourism in the United States: a single-center experience. Clin J Am Soc Nephrol. 2008;3(6):1820–8.

    PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Transplant and Immunocompromised Host Infectious Diseases, Infectious Diseases Division, Massachusetts General Hospital, Harvard Medical School, 55 Fruit Street, Cox 5, Boston, MA, 02114, USA

    Camille Nelson Kotton M.D., F.I.D.S.A., F.A.S.T.

Authors
  1. Camille Nelson Kotton M.D., F.I.D.S.A., F.A.S.T.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Camille Nelson Kotton M.D., F.I.D.S.A., F.A.S.T. .

Editor information

Editors and Affiliations

  1. Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden

    Per Ljungman

  2. Tufts University School of Medicine Tufts Medical Center, Boston, MA, USA

    David Snydman

  3. University of Washington Fred Hutchinson Cancer Research Center, Seattle, WA, USA

    Michael Boeckh

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Kotton, C.N. (2016). Travel Medicine, Vaccines, and Transplant Tourism. In: Ljungman, P., Snydman, D., Boeckh, M. (eds) Transplant Infections. Springer, Cham. https://doi.org/10.1007/978-3-319-28797-3_50

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-28797-3_50

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-28795-9

  • Online ISBN: 978-3-319-28797-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation